Healthcare -
Biotechnology - NASDAQ - US
$ 118.0
0.803 %
$ 11.3 B
Market Cap
76.62
P/E
SRPT - REVENUE
Revenue SRPT - Sarepta Therapeutics, Inc.
1.24 B
LAST VALUE
33.09%
2 YEAR CAGR
32.80%
5 YEAR CAGR
56.38%
10 YEAR CAGR